Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm? | Zendy

SPYROPOULOS A. C. | Zendy; GOLDENBERG N. A. | Zendy; KESSLER C. M. | Zendy; KITTELSON J. | Zendy; SCHULMAN S. | Zendy; TURPIE A. G. G. | Zendy; CUTLER N. R. | Zendy; HIATT W. R. | Zendy; HALPERIN J. L. | Zendy

Premium

Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?

Author(s) -

SPYROPOULOS A. C.,

GOLDENBERG N. A.,

KESSLER C. M.,

KITTELSON J.,

SCHULMAN S.,

TURPIE A. G. G.,

CUTLER N. R.,

HIATT W. R.,

HALPERIN J. L.

Publication year - 2012

Publication title -

journal of thrombosis and haemostasis

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.947

H-Index - 178

eISSN - 1538-7836

pISSN - 1538-7933

DOI - 10.1111/jth.12005

Subject(s) - rivaroxaban , medicine , dabigatran , antithrombotic , clinical trial , dosing , warfarin , direct thrombin inhibitor , apixaban , vitamin k antagonist , intensive care medicine , ximelagatran , pharmacology , atrial fibrillation

Spyropoulos AC, Goldenberg NA, Kessler CM, Kittelson J, Schulman S, Turpie AGG, Cutler NR, Hiatt WR, Halperin JL. Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm? J Thromb Haemost 2012; 10: 2621–4.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research